11.07.2015 Views

FA Family Newsletter Fall 04 - Fanconi Anemia Research Fund

FA Family Newsletter Fall 04 - Fanconi Anemia Research Fund

FA Family Newsletter Fall 04 - Fanconi Anemia Research Fund

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Recurring Clonal ChromosomalAbnormalitiescontinued from 3Kevin McQueen, team leader, and other <strong>FA</strong> families plan fundraising efforts at Camp Sunshine.<strong>Fund</strong>raising for <strong>FA</strong> <strong>Research</strong>:Join the Winning Team!!In an effort to increase fundraising by <strong>FA</strong> families, the <strong>FA</strong> <strong>Research</strong> <strong>Fund</strong>has developed regional fundraising teams. Kevin McQueen, Mark Pearl, andMike Vangel, who are all <strong>FA</strong> parents and members of the <strong>Fund</strong>’s Board ofDirectors, have volunteered to develop these teams to provide support tofamilies in their fundraising efforts. Kevin, Mark, and Mike are aided byfundraising team leaders Peg Padden, Lisa and Jack Nash, Kim and JohnConnelly, Rachel Grossman, Brian Horrigan, Donny Burkin, PatrickGleason, and Randy Bloxom. The team leaders will be contacting <strong>FA</strong>parents in their respective geographical areas to assist them with their fundraisingplans. ◆Our Experience with PGDcontinued from 9truly feel their support and knowthey’re rooting for us as much as ourfamily and friends. For half of ourattempts, we haven’t had a healthy,matched embryo to transfer, and weknow they share our frustration.Statistically, 3 out of every 4 embryos(75%) will not be affected with <strong>FA</strong>,and 1 out of every 4 embryos (25%)will be an HLA match. Therefore,25% of the 75% (which equals 19%)will achieve both and be an unaffectedmatch. Since not all of the eggsretrieved will be mature and willfertilize into embryos, these aretough hurdles. But we truly believe itHAS to work eventually, and weknow we’ll be successful if we’re giventhe time to try. When the three of ushold that baby in our arms, all of theeffort and disappointments will beforgotten and replaced with purejoy. ◆studies will be important to determinethe time frame between theoccurrence of a chromosome abnormalityand the development ofabnormal morphology. Only 6% ofpatients with normal cytogeneticshad MDS or AML.G-banded chromosome analysiscurrently represents the best methodfor identifying all types of chromosomeabnormalities. However, thefinding that abnormalities of chromosomes1, 3, and 7 comprise thebulk of abnormalities seen in thebone marrow of <strong>FA</strong> patients presentspossibilities for supplementing andincreasing the sensitivity of screeningstrategies. For example, if G-bandedstudies are normal, FISH can be usedto rapidly screen additional cells forthe presence of 1, 3, and 7 abnormalities.Further, peripheral blood FISHstudies might provide a means ofscreening in between annual bonemarrow examinations.At the University of Minnesota,the following clinical strategy is followed:bone marrow chromosomesare analyzed once per year by G-banding. If an abnormal clone isdetected, the finding is discussedwith the hematopathologist andtreating physician. If there is noMDS or AML present, the bonemarrow is then monitored every fourmonths. If there is evidence of MDSor AML, treatment options are discussed.In general, the treating physicianconsiders the presence orabsence of abnormal clones, theappearance of the cells of the bonemarrow, the availability of a matchedbone marrow donor, and the clinicalcondition of the patient in makingtreatment decisions. ◆18 <strong>FA</strong> <strong>Family</strong> <strong>Newsletter</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!